Cision PR Newswire

AccidentAccidentAir PollutionAll NewsAnnoucementArgricultureArtASEANBook

Ascletis’ Oral Small Molecule GLP-1, ASC30, Demonstrated Placebo-Adjusted HbA1c Reduction of 1.7% at 12 Weeks from Its U.S. Phase II Study in Participants with...

- ASC30 reduced HbA1c by a placebo-adjusted 1.7%, 1.6% and 1.7% from baseline for 40 mg, 60 mg and 80 mg, respectively, at 12 weeks, the...

OnCusp Therapeutics Receives FDA Fast Track Designation for CUSP06 for the Treatment of Platinum-Resistant Ovarian Cancer

PRINCETON, N.J., Feb. 12, 2025 /PRNewswire/ -- OnCusp Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated...

Actinogen announces peer-reviewed clinical pharmacology manuscript for Xanamem (emestedastat) published in Clinical Pharmacology in Drug Development journal

Confirms...

[Herald Interview] Fescaro CTO stresses comprehensive approach to vehicle cybersecurity

SUWON, South Korea, Feb. 12, 2025 /PRNewswire/ -- This is an interview with Fescaro Chief Technology officer Lee Hyun-jung published in The Korea Herald:...

HKMU receives precious manuscripts and relics from Eileen Chang, Stephen Soong and Mae Fong Soong; Literary treasures to be digitally preserved to promote modern...

HONG KONG, Feb. 12, 2025 /PRNewswire/ -- This year marks the 30th anniversary of the passing of renowned Chinese writer Eileen Chang, who has...

IFS named a Leader in two IDC MarketScape 2024-2025 Vendor Assessments: Manufacturing ERP and Remanufacturing Management Software

LONDON, Feb. 12, 2025 /PRNewswire/ -- IFS, the leading enterprise cloud and Industrial AI software provider, announces that it has been positioned as a...

Over 50% Indonesian consumers plan to increase shopping budgets this Ramadan: Glance report

'Ramadan 2025 at a Glance' report provides marketers actionable consumer insights to craft winning strategies during Ramadan Report Highlights: ...
1...4,2374,2384,239...4,481Page 4,238 of 4,481